Carbonic anhydrase IX deposits are associated with increased ascending aortic dilatation

Eetu Niinimaki1, Petteri Muola1, Seppo Parkkila1,2

  • 1b School of Medicine , University of Tampere , Tampere , Finland ;

Insights

Carbonic anhydrase IX (CA IX) deposits in the aorta are linked to increased inflammation and size. This suggests elevated CA IX activity may contribute to ascending aortic dilatation.

Area of Science:

  • Cardiovascular Research
  • Pathology
  • Biochemistry

Background:

  • Carbonic anhydrase IX (CA IX) expression is a known marker of local hypoxia.
  • Ascending aortic dilatation is a serious cardiovascular condition often associated with inflammation and tissue remodeling.

Purpose of the Study:

  • To investigate the association between carbonic anhydrase IX (CA IX) deposits and ascending aortic dilatation.
  • To explore the relationship between CA IX expression and adventitial inflammation in the ascending aorta.

Main Methods:

  • Histological analysis of ascending aorta specimens from 30 surgical patients.
  • Assessment of CA IX expression, inflammatory cell presence (leukocytes, plasma cells, macrophages), smooth muscle cells, cell proliferation, elastin, and collagen.
  • Grouping of samples based on the presence or absence of CA IX deposits.

Main Results:

  • CA IX-positive deposits were found in the adventitia of 20 out of 30 patients.
  • CA IX-positive samples exhibited significantly increased adventitial inflammation compared to CA IX-negative samples (p < 0.01).
  • Patients with CA IX-positive staining showed a significantly larger mean ascending aorta diameter (63 ± 3 mm vs 53 ± 2 mm, p < 0.02), confirmed by ROC analysis (AUC 0.766, p = 0.020).

Conclusions:

  • The presence of CA IX deposits in aortic specimens is associated with ascending aortic dilatation.
  • Increased carbonic anhydrase (CA) activity, indicated by CA IX positivity, may play a role in the pathogenesis of ascending aortic dilatation.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
834
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
502
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
733
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
600
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643